Review ArticleInternational Journal of Basic & Clinical Pharmacology

Publication:
Cure of human immunodeficiency virus/acquired immune deficiency syndrome: promising future prospects at horizon

Int J Basic Clin Pharmacol. 2015;4(4):640-643.DOI10.18203/2319-2003.ijbcp20150364

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Acquired immune deficiency syndrome (AIDS) is a disease caused by humanimmunodeficiency virus and characterized by profound immunosuppression thatleads to opportunistic infections, secondary neoplasms, and neurologic complications.AIDS is among the leading causes of death worldwide. Current therapeutic optionsare directed only toward management of AIDS, but not toward its prevention or cure.In addition, it also possesses numerous problems like drug resistance, drug toxicity,drug interactions, non-adherence to therapy, life-long and expensive treatment, etc.Recent years in drug development have shown promising prospects for prevention/treatment/cure of AIDS like histone deacetylase inhibitors, Vpu ion channel inhibitors,viral decay acceleration, maturation inhibitors, tat antagonists, gene/stem cell therapy,and antiretroviral vaccines.

Keywords

Affiliations

  1. Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai Central, Mumbai, Maharashtra, India

Full item record